Takeda Oncology Here2Assist RapidStart Program: Ninlaro
Funded
About
The Takeda Oncology Here2Assist RapidStart Program: Ninlaro provides eligible patients with a 1-month supply of Ninlaro at no charge. This program benefits those new to therapy who experience a delay in insurance coverage determination. Patients must have a valid prescription for Takeda Oncology medication and be enrolled in the Takeda Oncology Here2Assist Program. The use of the Takeda Oncology Here2Assist RapidStart Program ensures timely access to Ninlaro, enhancing patient support during initial treatment phases.
Insurance requirements: Commercially insured, Underinsured
Enrollment Forms
Enrollment Form
Benefits
•1 maximum fills per year
Program Requirements
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•The RapidStart Program provides a 1month supply of treatment of the prescribed Takeda Oncology medication at no charge for eligible patients new to therapy experiencing a delay in insurance coverage determination
•Free product for the RapidStart Program will only be available through the RapidStart Program noncommercial specialty pharmacy
•A delay in coverage determination of at least 5 days is required for patients to be eligible for the RapidStart Program
•For assistance or additional information, call 8448176468, Option 2, MondayFriday, 8AM8PM ET
Enrollment Forms
Enrollment Form